or
forgot password

    • cancer clinical trials in babylon, NY

    • Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Schwartz Gynecologic Oncology, PLLC
    Babylon, New York 11702
    Ovarian Cancer
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Benjamin Schwartz, M.D.
    Babylon, New York 11702
    Ovarian Neoplasms
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    Gynecologic Oncology & Minimally Invasive Surgery
    Babylon, New York 11702
    Ovarian Neoplasms
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Schwartz Gynecologic Oncology, PLLC
    Babylon, New York 11702
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    Schwartz Gynecologic Oncology, PLLC
    Babylon, New York 11702
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
    Schwartz Gynecologic Oncology, PLLC
    Babylon, New York 11702
    Ovarian Cancer
    An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
    Schwartz Gynecologic Oncology, PLLC
    Babylon, New York 11702
    Ovarian Cancer
    Safety/Efficacy Study of a Drug to Reduce Thrombocytopenia in Patients Receiving Chemotherapy for Ovarian, Fallopian Tube or Peritoneal Cancer
    Schwartz Gynecologic Oncology, PLLC
    Babylon, New York 11702
    Thrombocytopenia, Neutropenia, Lymphopenia, Anemia